Table 1.
Baseline characteristics of 159 patients aged ≥ 80 years with covid-19.
| Characteristics | n (%) | |
| Gender, n (%) | Men: 76 (48) Women: 83 (52) | |
| Age, years, mean (SD) | 86 (4.1) | |
| Barthel index, median (IQR) | 90 (40–100) | |
| Dementia, n (%) | 50 (31) | |
| Charlson comorbidity index, median (IQR) | 5 (5–6) | |
| Diabetes mellitus, n (%) | 46 (29) | |
| Chronic obstructive pulmonary disease, n (%) | 17 (10.7) | |
| Cerebral vascular disease, n (%) | 18 (11.3) | |
| Coronary heart disease, n (%) | 25 (16) | |
| Cancer, n (%) | 21 (13) | |
| Chronic kidney disease, n (%) | 41 (26) | |
| Hypertension, n (%) | 120 (75.5) | |
| Symptoms on admission, n (%) | Fever: 118 (74) | |
| Cough: 68 (43) | ||
| Dyspnea: 80 (50.3) | ||
| Diarrhea: 19 (12) | ||
| Anosmia: 3 (2) | ||
| Odynophagia: 4 (3) | ||
| Ageusia: 10 (6.3%) | ||
| Headache: 3 (2) | ||
| Falls: 13 (8.2) | ||
| Classification of severity (World Health Organization), n (%) | Mild: 13 (8.2) | |
| Moderate: 83 (52.2) | ||
| Severe: 63 (39.6) | ||
| Place of origin, n (%) | Home: 104 (65.4) | |
| Nursing home: 55 (35) | ||
| Radiological pattern, n (%) | No pneumonia: 12 (7.5) | |
| Pneumonia 147 (92.5) | Unilateral lung involvement: 20 (14) | |
| Bilateral lung involvement: 127 (86) | ||
| Laboratory tests, mean (SD) | CRP: 10.7mg/dl (9.2) | |
| LDH: 337 U/L (152) | ||
| Ferritin: 694 ng/ml (879) | ||
| Lymphocyte count: 0.88 x109/L (0.5) | ||
| D-dimer: 2777 ng/ml (3982) | ||
| Treatment during hospitalization, n (%) | Triple treatment: 83 (78) ∗ | |
| Corticosteroids (mg/kg): 59 (37) | ||
| Biological therapies: 28 (17.6) | ||
| Deaths, n (%) | 53 (33.3) | |
| Days until hospital admission, median (IQR) | 5 (2–8) |
CRP = C-reactive protein, IQR = interquartile range, LDH = lactate dehydrogenase, SD = standard deviation, WHO = World Health Organization.
∗
Triple treatment: Lopinavir/Ritonavir, Hidroxicloroquine, and Azitromicine.